Zofran Zydis 8 mg oral lyophilisate
8 milligram(s) Oral lyophilisate
Generics List:
Ondansetron 8mg Film-coated tablets/oral lyophilisate
Compare
|
PA0896/036/008
Authorised: 13/07/1998
Novartis Ireland Limited
|
SPC
PIL
|
Zoftacot 3.35 mg/ml eye drops, solution in single-dose container
3.35 milligram(s)/millilitre Eye drops, solution
Compare
|
PA1107/013/001
Authorised: 23/06/2017
Laboratoires Thea
|
SPC
PIL
|
Zoladex 3.6 mg implant
3.6 milligram(s) Implant
Compare
|
PA1019/027/001
Authorised: 02/02/1999
AstraZeneca AB
|
SPC
PIL
|
Zoladex 3.6 mg implant
3.6 milligram(s) Implant
Compare
|
PPA1463/125/001
Authorised: 14/06/2019
IMED Healthcare Ltd.
|
SPC
PIL
|
Zoladex 3.6 mg Implant
3.6 milligram(s) Implant
Compare
|
PPA0465/188/001
Authorised: 21/12/2006
PCO Manufacturing Ltd.
|
SPC
PIL
|
Zoladex LA 10.8 mg Implant
10.8 milligram(s) Implant
Compare
|
PPA0465/188/002
Authorised: 21/12/2006
PCO Manufacturing Ltd.
|
SPC
PIL
|
Zoladex LA 10.8 mg implant
10.8 milligram(s) Implant
Compare
|
PPA1463/125/002
Authorised: 14/06/2019
IMED Healthcare Ltd.
|
SPC
PIL
|
Zoladex LA 10.8 mg implant
10.8 milligram(s) Implant
Compare
|
PA1019/027/002
Authorised: 03/01/2001
AstraZeneca AB
|
SPC
PIL
|
Zoldem 10 mg film coated tablets
10 milligram(s) Film-coated tablet
Compare
|
PA0577/048/001
Authorised: 30/06/2003
McDermott Laboratories Ltd., T/A Gerard Laboratories
|
SPC
PIL
|
Zoledronic Acid 4 mg / 5 mL Concentrate for solution for infusion
4 mg/5ml Concentrate for solution for infusion
Compare
|
PA1122/016/001
Authorised: 22/02/2013
Noridem Enterprises Ltd
|
SPC
PIL
|
Zoledronic Acid 4 mg/100 ml solution for infusion
4 mg/100 millilitre(s) Solution for infusion
Compare
|
PA2315/084/001
Authorised: 22/06/2018
Accord Healthcare Ireland Ltd.
|
SPC
PIL
|
Zoledronic acid 4 mg/5 ml concentrate for solution for infusion
4/5 milligram(s)/millilitre Concentrate for solution for infusion
Compare
|
PA2059/019/001
Authorised: 12/10/2012
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
|
Zoledronic Acid Accord
4mg/5 millilitre(s) Concentrate for solution for infusion
Compare
|
EU/1/13/834/001-003
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
EdM
|
Zoledronic acid Actavis
4/5 milligram(s)/millilitre Solution for infusion
Compare
|
EU/1/12/759/001-003
Actavis Group PTC ehf
|
SPC
PIL
IPAR
EdM
|
Zoledronic Acid Hospira
4/5 milligram(s)/millilitre Concentrate for solution for infusion
Compare
|
EU/1/12/800/001-002
Authorised: 19/11/2012
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
EdM
|
Zoledronic Acid Hospira
4/100 milligram(s)/millilitre Solution for infusion
Compare
|
EU/1/12/800/003
Authorised: 19/11/2012
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
EdM
|
Zoledronic Acid Hospira
5/100 milligram(s)/millilitre Solution for infusion
Compare
|
EU/1/12/800/004
Authorised: 19/11/2012
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Zoledronic acid medac
4/5 milligram(s)/millilitre Concentrate for solution for infusion
Compare
|
EU/1/12/779/001-003
Authorised: 03/08/2012
medac Gesellschaft für klinische Spezialpräparate mbH
|
SPC
PIL
IPAR
EdM
|
Zoledronic acid medac
4/100 milligram(s)/millilitre Solution for infusion
Compare
|
EU/1/12/779/004-006
medac Gesellschaft für klinische Spezialpräparate mbH
|
SPC
PIL
IPAR
EdM
|
Zoledronic acid Mylan
4/5 milligram(s)/millilitre Concentrate for solution for infusion
Compare
|
EU/1/12/786/001-003
Mylan S.A.S.
|
SPC
PIL
IPAR
EdM
|